Hwang, J., Dzimitrowicz, H., Shah, R., Ashcraft, K., George, D., Salama, A., & Zhang, T. (2021). 625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors. In Regular and Young Investigator Award Abstracts (pp. A655–A655). BMJ Publishing Group Ltd. https://doi.org/10.1136/jitc-2021-sitc2021.625

Hwang, Joyce, Hannah Dzimitrowicz, Riddhishkumar Shah, Kathleen Ashcraft, Daniel George, April Salama, and Tian Zhang. “625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors.” In Regular and Young Investigator Award Abstracts, A655–A655. BMJ Publishing Group Ltd, 2021. https://doi.org/10.1136/jitc-2021-sitc2021.625.

Hwang J, Dzimitrowicz H, Shah R, Ashcraft K, George D, Salama A, et al. 625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors. In: Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2021. p. A655–A655.

Hwang, Joyce, et al. “625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors.” Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, 2021, pp. A655–A655. Crossref, doi:10.1136/jitc-2021-sitc2021.625.

Hwang J, Dzimitrowicz H, Shah R, Ashcraft K, George D, Salama A, Zhang T. 625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors. Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2021. p. A655–A655.